Cytek Biosciences, Inc. Annual Selling and Marketing Expense in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Cytek Biosciences, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from 2020 to 2023.
  • Cytek Biosciences, Inc. Selling and Marketing Expense for the quarter ending June 30, 2024 was $12.3M, a 14.6% decline year-over-year.
  • Cytek Biosciences, Inc. Selling and Marketing Expense for the twelve months ending June 30, 2024 was $48.4M, a 11.8% increase year-over-year.
  • Cytek Biosciences, Inc. annual Selling and Marketing Expense for 2023 was $49.1M, a 47.9% increase from 2022.
  • Cytek Biosciences, Inc. annual Selling and Marketing Expense for 2022 was $33.2M, a 34.5% increase from 2021.
  • Cytek Biosciences, Inc. annual Selling and Marketing Expense for 2021 was $24.7M, a 64.9% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $49.1M +$15.9M +47.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
2022 $33.2M +$8.52M +34.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 $24.7M +$9.72M +64.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-13
2020 $15M Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.